Bio Products Laboratory Limited
PolandAll drugs from this manufacturer
-
The medicine is used for the prophylaxis and treatment of bleeding in patients with hemophilia A (congenital deficiency of factor VIII in the blood).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human blood coagulation factor viii 250 IU ATC: B02BD04
-
The medicine is used for the treatment and prevention of bleeding in people with haemophilia A (congenital deficiency of factor VIII in the blood).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human blood coagulation factor viii 500 IU ATC: B02BD04
-
The medicine is used to prevent and treat bleeding in people with hemophilia A (congenital deficiency of factor VIII in the blood).
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human blood coagulation factor viii 1000 IU ATC: B02BD04